In our subgroup analysis, the TPS model still showed superior performance in predicting the OS of AFP‐negative HCC patients with or without cirrhosis after liver resection and also showed superior performance in predicting early recurrence of AFP‐negative HCC patients without cirrhosis after liver resection. This evidence concerns the gene AFP and hepatocellular carcinoma.